Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
Zhejiang DTRM Biopharma
Zhejiang DTRM Biopharma
Oncternal Therapeutics, Inc
Celgene
Vifor Pharma
miRagen Therapeutics, Inc.
Incyte Corporation
Spectrum Pharmaceuticals, Inc
Gilead Sciences
University of Michigan Rogel Cancer Center
miRagen Therapeutics, Inc.
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Barbara Ann Karmanos Cancer Institute
European Association of Urology Research Foundation
City of Hope Medical Center
Alliance for Clinical Trials in Oncology
Baylor College of Medicine
City of Hope Medical Center
Seagen Inc.
Ariad Pharmaceuticals
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Children's Healthcare of Atlanta
HemaQuest Pharmaceuticals Inc.